FDA Consolidates Travel and IT Offices to Streamline Operations
The Food and Drug Administration (FDA) will consolidate offices responsible for travel and information technology (IT) but does not intend to reorganize the agency. These changes aim to streamline operations within the FDA. Specifically, the FDA will bring together various offices that manage travel logistics and IT infrastructure. While consolidating these support functions, the agency clarified it is not planning a broader reorganization that would affect its core operational structure or mission-critical departments. The FDA anticipates the consolidation will create efficiencies within the agency’s administrative processes.
Newsflash | Powered by GeneOnline AI
Date: April 30, 2025
LATEST
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Boehringer Ingelheim and Tempus AI Partner in Multi-Year Collaboration to Enhance Oncology Drug Development
2025-05-15
Study: Aligning U.S. Drug Prices with Europe Could Reduce American Life Expectancy by Six Months
2025-05-15